Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) EPS (Weighted Average and Diluted) (2021 - 2025)

Bio Essence (BIOE) has 5 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.01 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 133.33% year-over-year to $0.01; the TTM value through Jun 2025 reached -$0.04, down 300.0%, while the annual FY2024 figure was -$0.03, 0.0% changed from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.01 in Q3 2025 per BIOE's latest filing, up from -$0.01 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.01 in Q3 2025 and bottomed at -$0.03 in Q3 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.0, with a median of $0.0 recorded in 2022.
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 200.4% in 2022, then tumbled 301.04% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.0 in 2021, then surged by 135.16% to $0.01 in 2022, then surged by 48.72% to $0.01 in 2023, then crashed by 412.42% to -$0.03 in 2024, then skyrocketed by 133.33% to $0.01 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.01 in Q3 2025, -$0.01 in Q1 2025, and -$0.03 in Q3 2024.